阔达代云
Lv31
270 积分
2022-12-06 加入
-
A cross-industry survey on photosafety evaluation of pharmaceuticals after implementation of ICH S10
2小时前
已完结
-
Management of infusion-related reactions (IRRs) in patients receiving amivantamab in the CHRYSALIS study
12天前
已完结
-
Prediction of human hepatic clearance from in vivo animal experiments and in vitro metabolic studies with liver microsomes from animals and humans
24天前
已完结
-
Evaluation of Safety of Treatment With Anti–Epidermal Growth Factor Receptor Antibody Drug Conjugate MRG003 in Patients With Advanced Solid Tumors
1个月前
已完结
-
Soluble epidermal growth factor receptor (sEGFR/sErbB1) as a potential risk, screening, and diagnostic serum biomarker of epithelial ovarian cancer
2个月前
已关闭
-
BL-B01D1, a first-in-class EGFR–HER3 bispecific antibody–drug conjugate, in patients with locally advanced or metastatic solid tumours: a first-in-human, open-label, multicentre, phase 1 study
2个月前
已完结
-
BL-B01D1, a first-in-class EGFR–HER3 bispecific antibody–drug conjugate, in patients with locally advanced or metastatic solid tumours: a first-in-human, open-label, multicentre, phase 1 study
2个月前
已完结
-
A Phase I and pharmocokinetic study of exatecan mesylate administered as a protracted 21-day infusion in patients with advanced solid malignancies
3个月前
已完结
-
Biological efficacy of a chimeric antibody to the epidermal growth factor receptor in a human tumor xenograft model
4个月前
已完结
-
Novel Thienoduocarmycin–Trastuzumab ADC Demonstrates Strong Antitumor Efficacy with Favorable Safety Profile in Preclinical Studies
4个月前
已完结